secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bluejay Diagnostics, Inc. (BJDX)
CIK:        0001704287
Form:       8-K
Filed at:   2024-05-16T23:59:59+00:00
Accession:  0001213900-24-044034
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bluejay Diagnostics increases authorized shares from 7.5M to 50M; shareholders approve reverse stock split up to 1:10
--------------------------------------------------------------------------------

- Authorized shares of common stock increased from 7,500,000 to 50,000,000 via amendment filed May 14, 2024.
- Stockholders approved reverse stock split at ratio of 1-for-2 to 1-for-10; board to decide final ratio and timing.
- Directors Donald Chase, Neil Dey, Svetlana Dey, Fred Zeidman, Gary Gemignani, and Douglas Wurth re-elected.
- Ratification of Wolf & Company, P.C. as independent auditor for FY2024 approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/0001213900-24-044034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1704287/000121390024044034/ea020636401-8k_bluejay.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-044034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer